QualioRa

FAQ

Questions around FDA readiness, inspections, and botanical compliance.

Guidance for botanical manufacturers entering or operating in the US market.

Topics

01

Getting Started

02

FSMA & FSVP

03

Registration & us Agent

04

Audits & Inspection

01

Getting Started

We've never engaged with FDA before. Where do we begin?

We typically start with a facility diagnostic — a structured gap analysis against the regulations applicable to your product class (FSMA Subpart C/G for foods, 21 CFR 111 for dietary supplements). The output is a prioritised compliance roadmap with timelines and resource estimates.

Most international botanical manufacturers reach a defensible compliance posture within 4 to 9 months, depending on facility complexity, existing QMS maturity, and supplier network size. We design phased rollouts so you can begin shipping while later stages mature.

Yes. We support emerging exporters preparing their first US shipment, mid-market manufacturers scaling distribution, and established suppliers responding to FDA observations or Warning Letters.

02

FSMA & FSVP

FSMA is the broader Food Safety Modernization Act. FSVP — Foreign Supplier Verification Program — is one specific FSMA rule that places obligations on US importers to verify their foreign suppliers. If you sell into the US through an importer, both regimes affect you.

Generally, dietary supplements are regulated under 21 CFR 111 (cGMP for dietary supplements) rather than FSMA preventive controls. However, ingredients that may be used in conventional foods can fall under FSMA. We help clarify which framework governs your specific products.

03

Registration &us Agent

We typically start with a facility diagnostic — a structured gap analysis against the regulations applicable to your product class (FSMA Subpart C/G for foods, 21 CFR 111 for dietary supplements). The output is a prioritised compliance roadmap with timelines and resource estimates.

Most international botanical manufacturers reach a defensible compliance posture within 4 to 9 months, depending on facility complexity, existing QMS maturity, and supplier network size. We design phased rollouts so you can begin shipping while later stages mature.

04

Audits & Inspection

Yes. FDA conducts foreign facility inspections, particularly for high-priority categories. Frequency has increased in recent years. Even without an on-site inspection, FDA may issue Import Alerts or hold shipments based on records reviews.

We provide rapid-response remediation: root-cause analysis, CAPA development, written response drafting, and ongoing monitoring. Time matters — FDA expects substantive responses within 15 working days for Warning Letters.

Speak with a specialist directly.